[ET Net News Agency, 18 August 2021] Sanai Health Industry Group Company Limited
(01889) said the group is expected to record a net profit attributable to the shareholders
of the company of approximately RMB6 million for the six months ended 30 June 2021, as
compared to approximately RMB2 million for the corresponding period in 2020.
The increase was mainly attributable to (i) the increase in sales of self-produced
pharmaceutical products with relatively high gross profit margin; and (ii) a drop in the
distribution costs, administrative and other expenses due to the significant reduction in
the operation of other general trading business. (RC)